STAAR Surgical Announces Strategic Alliance Agreement with Dr. Tobias Neuhann in Germany, A Model for Collaboration with Sing...
October 09 2018 - 7:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, today announced a multi-year
Strategic Alliance Agreement with Dr. Tobias Neuhann of the
Augenklinik am Marienplatz (Eye Clinic at Marienplatz) in Munich,
Germany. The agreement serves as a global partnership model for
smaller and single site refractive surgery eye clinics that aim to
provide STAAR's EVO Visian ICL™ intraocular lenses as a primary and
premium option for patients seeking visual freedom from spectacles
and contact lenses.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20181009005172/en/
EVO Visian ICL Flying Phantom (Photo:
Business Wire)
Caren Mason, President & CEO of STAAR, stated, “Our
agreement with Dr. Tobias Neuhann highlights the collaborative
excellence possible between STAAR and ophthalmologists operating
clinics outside large hospital, university and multi-site settings.
Offering many of the benefits of our larger strategic cooperation
agreements to these clinics is an important component of STAAR’s
growth strategy. Dr. Neuhann is a pioneer with a long history of
excellence working with the ICL including our latest generation of
the EVO family of lenses. His passion for the ICL is shared by his
family. His son, Raphael Neuhann, is on staff at Augenklinik am
Marienplatz as a dedicated ICL surgeon. The family also loves
sailing and sails a Flying Phantom catamaran as part of an EVO
Visian ICL branded sailing team. The catamaran prominently features
EVO as part of STAAR’s 'Break Free From Glasses' campaign and
illustrates one aspect of our company’s creative approach to
marketing with our ophthalmology customers. We are thrilled to
formally expand our collaboration with this highly-regarded doctor
and his family’s clinic.”
“My clinic and staff look forward to further deepening our
relationship with STAAR and its stellar family of ICL lenses as an
official Strategic Alliance Partner. We are committed to providing
STAAR’s ICL lens, and the associated implantation procedure that
preserves the natural anatomy of the eye, as a primary and premium
option for patients wanting to experience high quality vision,”
stated Dr. Tobias Neuhann, Practice Owner and Medical Head of
Augenklinik am Marienplatz. “I have successfully implanted the ICL
lenses in my wife’s eyes and hundreds of additional patients
seeking visual freedom from spectacles and contact lenses. We
believe the additional patient education, marketing and support
provided by STAAR under this strategic alliance will facilitate our
commitment to accelerating the growth of the ICL in our practice,”
concluded Dr. Neuhann.
In January 2016 STAAR Surgical Company announced the first
Strategic Cooperation Agreements with two of the largest and most
respected eye hospitals in the world. The Strategic Alliance
Agreement with Dr. Tobias Neuhann of the Augenklinik am Marienplatz
includes similar marketing, patient education and surgeon training
support provided by STAAR. The agreements are tailored and
optimized for the unique needs of smaller and single site
refractive centers while providing STAAR with committed levels of
growth by the clinic and premium and primary positioning of the ICL
family of lenses.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 30 years, designs, develops, manufactures and markets
implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients,
lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR’s lens used in
refractive surgery is called an Implantable Collamer® Lens or
“ICL”, which includes the EVO Visian ICL™ product line. More than
900,000 Visian ICLs have been implanted to date. To learn more
about the ICL go to: www.discovericl.com. STAAR has approximately
400 full-time equivalent employees and markets lenses in over 75
countries. Headquartered in Monrovia, CA, the company operates
manufacturing facilities in Aliso Viejo, CA and Monrovia, CA. For
more information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181009005172/en/
Investors & MediaEVC GroupBrian Moore,
310-579-6199Doug Sherk, 415-652-9100
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Mar 2024 to Apr 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Apr 2023 to Apr 2024